Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group

Blood. Volume 118, Issue 11: p.3080-3087, 16 June 2011, 10.1182/blood-2011-03-341412

We sequenced 120 candidate genes in 187 high-risk childhood B-precursor acute lymphoblastic leukemias, the largest pediatric cancer genome sequencing effort reported to date. Integrated analysis of 179 validated somatic sequence mutations with genome-wide copy number alterations and gene expression profiles revealed a high frequency of recurrent somatic alterations in key signaling pathways, including B-cell development/differentiation (68% of cases), the TP53/RB tumor suppressor pathway (54%), Ras signaling (50%), and Janus kinases (11%). Recurrent mutations were also found in ETV6 (6 cases), TBL1XR1 (3), CREBBP (3), MUC4 (2), ASMTL (2), and ADARB2 (2). The frequency of mutations within the 4 major pathways varied markedly across genetic subtypes. Among 23 leukemias expressing a BCR-ABL1-like gene expression profile, 96% had somatic alterations in B-cell development/differentiation, 57% in JAK, and 52% in both pathways, whereas only 9% had Ras pathway mutations. In contrast, 21 cases defined by a distinct gene expression profile coupled with focal ERG deletion rarely had B-cell development/differentiation or JAK kinase alterations but had a high frequency (62%) of Ras signaling pathway mutations. These data extend the range of genes that are recurrently mutated in high-risk childhood B-precursor acute lymphoblastic leukemia and highlight important new therapeutic targets for selected patient subsets.

Supplemental Data Files

• GDC Manifests
  • Controlled-Access Data Download Manifest (5 Files)
  • Open-Access Data Download Manifest (17 Files)

• Copy Number Array
  • TARGET ALL P1 Copy Number Array Level 1 Data (Controlled)
  • TARGET ALL P1 Copy Number Array Level 2 Data (Controlled)
  • TARGET ALL P1 Copy Number Array Level 3 Data
  • TARGET ALL P1 Copy Number Array Level 4 Data
  • TARGET ALL P1 Copy Number Array Metadata
• Gene Expression
  • TARGET ALL P1 Gene Expression Array Level 1 Data
  • TARGET ALL P1 Gene Expression Array Level 2 Data
  • TARGET ALL P1 Gene Expression Array Level 3 Data
  • TARGET ALL P1 Gene Expression Array Level 4 Data
  • TARGET ALL P1 Gene Expression Array Metadata
• mRNA-Seq
  • TARGET ALL P1 mRNA-seq Level 3 Data
  • TARGET ALL P1 mRNA-seq Level 3 Data (Controlled)
  • TARGET ALL P1 mRNA-seq Metadata
• Kinome
  • TARGET ALL P1 Kinome Metadata
  • TARGET ALL P1 Kinome Level 1 Data (Controlled)
• WGS
  • TARGET ALL P1 and P2 WGS L3 Data
  • TARGET ALL P1 and P2 WGS L3 Data (Controlled)
  • TARGET ALL P1 and P2 WGS L4 Data
  • TARGET ALL P1 and P2 WGS Metadata
• Additional Information
  • TARGET ALL P1 Sample Matrix
  • TARGET ALL P1 ID Mapping Information

Additional Resources

• TARGET ALL P1 at SRA (link is external) NCBI

Instructions for Data Download

Open Access Data

1. Download the appropriate manifest file from the publication page
2. Use the manifest file to download data using the GDC Data Transfer Tool (DTT) or the GDC API
   • GDC DTT (Download, User's Guide)
   • GDC API (User’s Guide)

Controlled Access Data

1. Download the appropriate manifest file from the publication page
2. Download a token from the GDC Data Portal
   • GDC Data Portal (Launch, User’s Guide)
3. Use the manifest file and token to download data using the GDC DTT or the GDC API
   • GDC DTT (Download, User’s Guide)
   • GDC API (User’s Guide)

For assistance, please contact the GDC Help Desk: support@nci-gdc.datacommons.io